MedPath

Evaluation of the effect of pyloricin soft gel on Helicobacter pylori infectio

Not Applicable
Recruiting
Conditions
Helicobacter pylori infection.
Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
B96.81
Registration Number
IRCT20130211012438N27
Lead Sponsor
Barij Research Center of Medicinal Herbs
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Confirmation of Helicobacter Pylori infection by gastroenterologist with the help of a sample of pathology taken in the endoscopy or a positive result of anti-Helicobacter pylori antibodies in the serum sample of patients
Patients with functional dyspepsia or gastroduodenal ulcer have indications of eradication of Helicobacter pylori infection

Exclusion Criteria

A person with advanced chronic disease
Any allergy to the drugs used in the study
Pregnancy or breastfeeding
Substance abuse or alcohol use
Having a history of treatment to eradicate Helicobacter pylori infection
Taking antibiotics or bismuth 4 weeks before entering the study
Constipation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical signs. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Eradication rate of helicobacter pylori. Timepoint: after 1 months from the end of treatment. Method of measurement: stool antigen for helicobacter pylori.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath